A new hope for bacterial infections?

The Daptomincine was the last antibiotic included into the war against the bacterias and it was in 1987. Now a research group led by Losee Ling, from NovoBiotic Pharmaceuticals, have just published the results obtained if a new antibiotic named Teixobactin. This new antibiotic, is able to eliminate the colitis, tuberculosis, conjunctivitis, meningitis or pneumonia-causing…

Synthelia Organics launchs the new product catalogue, which highlights its extensive scope of products.

The new 42-products catalog clearly illustrates the great scope of products that Synthelia could provide to its customers: from boronic acids, to aminoacids, heterocycles or chiral aminoalcohols. These intermediates are widely exemplified in diverse patent applications in literature or presented in multiple medchem groups SARs. These materials come from the experience of Synthelia Organics in…